APO Research
Talk to an analyst

APO RESEARCH · REPORT

Gene Therapy Products

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Gene Therapy Products Market Analysis and Forecast 2026-2032

19 December 2025191 pages

Choose your research edition.

Industry ResearchGene Therapy Products Industry Research Report 2026119 pages · $2,950 USDIndustry Growth & TrendsGlobal Gene Therapy Products Industry Growth and Trends Forecast to 203298 pages · $3,450 USDMarket StructureGlobal Gene Therapy Products Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032180 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Gene Therapy Products Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Gene Therapy Products Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

The global Gene Therapy Products market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Gene Therapy Products is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Gene Therapy Products is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Gene Therapy Products is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Gene Therapy Products is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Gene Therapy Products include Advantagene, Avalanche Bio, Bluebird Bio, Celladon, Dimension Therapeutics, Sangamo, Spark Therapeutics and Vical Inc., etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Gene Therapy Products, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Gene Therapy Products, also provides the sales of main regions and countries. Of the upcoming market potential for Gene Therapy Products, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Gene Therapy Products sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Gene Therapy Products market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Gene Therapy Products sales, projected growth trends, production technology, application and end-user industry.

Gene Therapy Products Segment by Company

Advantagene

Avalanche Bio

Bluebird Bio

Celladon

Dimension Therapeutics

Sangamo

Spark Therapeutics

Vical Inc.

Gene Therapy Products Segment by Type

Ex vivo

In Vivo

Gene Therapy Products Segment by Application

Cardiovascular disease

Monogenic

Infectious disease

Cancer

Other

Gene Therapy Products Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Gene Therapy Products market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Gene Therapy Products and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Gene Therapy Products.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Gene Therapy Products in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Gene Therapy Products manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Gene Therapy Products sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Gene Therapy Products Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Ex vivo Major Manufacturers Table 3. In Vivo Major Manufacturers Table 4. Global Gene Therapy Products Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Cardiovascular disease Major Manufacturers Table 6. Monogenic Major Manufacturers Table 7. Infectious disease Major Manufacturers Table 8. Cancer Major Manufacturers Table 9. Other Major Manufacturers Table 10. Gene Therapy Products Industry Trends Table 11. Gene Therapy Products Industry Drivers Table 12. Gene Therapy Products Industry Opportunities and Challenges Table 13. Gene Therapy Products Industry Restraints Table 14. Global Gene Therapy Products Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 15. Global Gene Therapy Products Revenue by Region (2021-2026) & (US$ Million) Table 16. Global Gene Therapy Products Revenue by Region (2027-2032) & (US$ Million) Table 17. Global Gene Therapy Products Revenue Market Share by Region (2021-2026) Table 18. Global Gene Therapy Products Revenue Market Share by Region (2027-2032) Table 19. Global Gene Therapy Products Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Units) Table 20. Global Gene Therapy Products Sales by Region (2021-2026) & (K Units) Table 21. Global Gene Therapy Products Sales by Region (2027-2032) & (K Units) Table 22. Global Gene Therapy Products Sales Market Share by Region (2021-2026) Table 23. Global Gene Therapy Products Sales Market Share by Region (2027-2032) Table 24. Global Gene Therapy Products Revenue by Manufacturers (US$ Million) & (2021-2026) Table 25. Global Gene Therapy Products Revenue Market Share by Manufacturers (2021-2026) Table 26. Global Gene Therapy Products Sales by Manufacturers (US$ Million) & (2021-2026) Table 27. Global Gene Therapy Products Sales Market Share by Manufacturers (2021-2026) Table 28. Global Gene Therapy Products Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 29. Global Gene Therapy Products Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 30. Global Gene Therapy Products Key Manufacturers Manufacturing Sites & Headquarters Table 31. Global Gene Therapy Products Manufacturers, Product Type & Application Table 32. Global Gene Therapy Products Manufacturers' Establishment Date Table 33. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 34. Global Gene Therapy Products by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 35. Global Gene Therapy Products Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 36. Global Gene Therapy Products Revenue by Type (2021-2026) & (US$ Million) Table 37. Global Gene Therapy Products Revenue by Type (2027-2032) & (US$ Million) Table 38. Global Gene Therapy Products Revenue Market Share by Type (2021-2026) Table 39. Global Gene Therapy Products Revenue Market Share by Type (2027-2032) Table 40. Global Gene Therapy Products Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 41. Global Gene Therapy Products Sales by Type (2021-2026) & (K Units) Table 42. Global Gene Therapy Products Sales by Type (2027-2032) & (K Units) Table 43. Global Gene Therapy Products Sales Market Share by Type (2021-2026) Table 44. Global Gene Therapy Products Sales Market Share by Type (2027-2032) Table 45. Global Gene Therapy Products Price by Type (2021-2026) & (US$/Unit) Table 46. Global Gene Therapy Products Price by Type (2027-2032) & (US$/Unit) Table 47. Global Gene Therapy Products Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Gene Therapy Products Revenue by Application (2021-2026) & (US$ Million) Table 49. Global Gene Therapy Products Revenue by Application (2027-2032) & (US$ Million) Table 50. Global Gene Therapy Products Revenue Market Share by Application (2021-2026) Table 51. Global Gene Therapy Products Revenue Market Share by Application (2027-2032) Table 52. Global Gene Therapy Products Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 53. Global Gene Therapy Products Sales by Application (2021-2026) & (K Units) Table 54. Global Gene Therapy Products Sales by Application (2027-2032) & (K Units) Table 55. Global Gene Therapy Products Sales Market Share by Application (2021-2026) Table 56. Global Gene Therapy Products Sales Market Share by Application (2027-2032) Table 57. Global Gene Therapy Products Price by Application (2021-2026) & (US$/Unit) Table 58. Global Gene Therapy Products Price by Application (2027-2032) & (US$/Unit) Table 59. Advantagene Company Information Table 60. Advantagene Business Overview Table 61. Advantagene Gene Therapy Products Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 62. Advantagene Gene Therapy Products Product Portfolio Table 63. Advantagene Recent Development Table 64. Avalanche Bio Company Information Table 65. Avalanche Bio Business Overview Table 66. Avalanche Bio Gene Therapy Products Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 67. Avalanche Bio Gene Therapy Products Product Portfolio Table 68. Avalanche Bio Recent Development Table 69. Bluebird Bio Company Information Table 70. Bluebird Bio Business Overview Table 71. Bluebird Bio Gene Therapy Products Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 72. Bluebird Bio Gene Therapy Products Product Portfolio Table 73. Bluebird Bio Recent Development Table 74. Celladon Company Information Table 75. Celladon Business Overview Table 76. Celladon Gene Therapy Products Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 77. Celladon Gene Therapy Products Product Portfolio Table 78. Celladon Recent Development Table 79. Dimension Therapeutics Company Information Table 80. Dimension Therapeutics Business Overview Table 81. Dimension Therapeutics Gene Therapy Products Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 82. Dimension Therapeutics Gene Therapy Products Product Portfolio Table 83. Dimension Therapeutics Recent Development Table 84. Sangamo Company Information Table 85. Sangamo Business Overview Table 86. Sangamo Gene Therapy Products Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 87. Sangamo Gene Therapy Products Product Portfolio Table 88. Sangamo Recent Development Table 89. Spark Therapeutics Company Information Table 90. Spark Therapeutics Business Overview Table 91. Spark Therapeutics Gene Therapy Products Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 92. Spark Therapeutics Gene Therapy Products Product Portfolio Table 93. Spark Therapeutics Recent Development Table 94. Vical Inc. Company Information Table 95. Vical Inc. Business Overview Table 96. Vical Inc. Gene Therapy Products Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 97. Vical Inc. Gene Therapy Products Product Portfolio Table 98. Vical Inc. Recent Development Table 99. North America Gene Therapy Products Revenue by Type (2021-2026) & (US$ Million) Table 100. North America Gene Therapy Products Revenue by Type (2027-2032) & (US$ Million) Table 101. North America Gene Therapy Products Sales by Type (2021-2026) & (K Units) Table 102. North America Gene Therapy Products Sales by Type (2027-2032) & (K Units) Table 103. North America Gene Therapy Products Sales Price by Type (2021-2026) & (US$/Unit) Table 104. North America Gene Therapy Products Sales Price by Type (2027-2032) & (US$/Unit) Table 105. North America Gene Therapy Products Revenue by Application (2021-2026) & (US$ Million) Table 106. North America Gene Therapy Products Revenue by Application (2027-2032) & (US$ Million) Table 107. North America Gene Therapy Products Sales by Application (2021-2026) & (K Units) Table 108. North America Gene Therapy Products Sales by Application (2027-2032) & (K Units) Table 109. North America Gene Therapy Products Sales Price by Application (2021-2026) & (US$/Unit) Table 110. North America Gene Therapy Products Sales Price by Application (2027-2032) & (US$/Unit) Table 111. North America Gene Therapy Products Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 112. North America Gene Therapy Products Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 113. North America Gene Therapy Products Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 114. North America Gene Therapy Products Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 115. North America Gene Therapy Products Sales by Country (2021-2026) & (K Units) Table 116. North America Gene Therapy Products Sales by Country (2027-2032) & (K Units) Table 117. North America Gene Therapy Products Sales Price by Country (2021-2026) & (US$/Unit) Table 118. North America Gene Therapy Products Sales Price by Country (2027-2032) & (US$/Unit) Table 119. United States Gene Therapy Products Revenue (2021-2032) & (US$ Million) Table 120. Canada Gene Therapy Products Revenue (2021-2032) & (US$ Million) Table 121. Europe Gene Therapy Products Revenue by Type (2021-2026) & (US$ Million) Table 122. Europe Gene Therapy Products Revenue by Type (2027-2032) & (US$ Million) Table 123. Europe Gene Therapy Products Sales by Type (2021-2026) & (K Units) Table 124. Europe Gene Therapy Products Sales by Type (2027-2032) & (K Units) Table 125. Europe Gene Therapy Products Sales Price by Type (2021-2026) & (US$/Unit) Table 126. Europe Gene Therapy Products Sales Price by Type (2027-2032) & (US$/Unit) Table 127. Europe Gene Therapy Products Revenue by Application (2021-2026) & (US$ Million) Table 128. Europe Gene Therapy Products Revenue by Application (2027-2032) & (US$ Million) Table 129. Europe Gene Therapy Products Sales by Application (2021-2026) & (K Units) Table 130. Europe Gene Therapy Products Sales by Application (2027-2032) & (K Units) Table 131. Europe Gene Therapy Products Sales Price by Application (2021-2026) & (US$/Unit) Table 132. Europe Gene Therapy Products Sales Price by Application (2027-2032) & (US$/Unit) Table 133. Europe Gene Therapy Products Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 134. Europe Gene Therapy Products Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 135. Europe Gene Therapy Products Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 136. Europe Gene Therapy Products Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 137. Europe Gene Therapy Products Sales by Country (2021-2026) & (K Units) Table 138. Europe Gene Therapy Products Sales by Country (2027-2032) & (K Units) Table 139. Europe Gene Therapy Products Sales Price by Country (2021-2026) & (US$/Unit) Table 140. Europe Gene Therapy Products Sales Price by Country (2027-2032) & (US$/Unit) Table 141. Germany Gene Therapy Products Revenue (2021-2032) & (US$ Million) Table 142. France Gene Therapy Products Revenue (2021-2032) & (US$ Million) Table 143. U.K. Gene Therapy Products Revenue (2021-2032) & (US$ Million) Table 144. Italy Gene Therapy Products Revenue (2021-2032) & (US$ Million) Table 145. Netherlands Gene Therapy Products Revenue (2021-2032) & (US$ Million) Table 146. China Gene Therapy Products Revenue by Type (2021-2026) & (US$ Million) Table 147. China Gene Therapy Products Revenue by Type (2027-2032) & (US$ Million) Table 148. China Gene Therapy Products Sales by Type (2021-2026) & (K Units) Table 149. China Gene Therapy Products Sales by Type (2027-2032) & (K Units) Table 150. China Gene Therapy Products Sales Price by Type (2021-2026) & (US$/Unit) Table 151. China Gene Therapy Products Sales Price by Type (2027-2032) & (US$/Unit) Table 152. China Gene Therapy Products Revenue by Application (2021-2026) & (US$ Million) Table 153. China Gene Therapy Products Revenue by Application (2027-2032) & (US$ Million) Table 154. China Gene Therapy Products Sales by Application (2021-2026) & (K Units) Table 155. China Gene Therapy Products Sales by Application (2027-2032) & (K Units) Table 156. China Gene Therapy Products Sales Price by Application (2021-2026) & (US$/Unit) Table 157. China Gene Therapy Products Sales Price by Application (2027-2032) & (US$/Unit) Table 158. Asia Gene Therapy Products Revenue by Type (2021-2026) & (US$ Million) Table 159. Asia Gene Therapy Products Revenue by Type (2027-2032) & (US$ Million) Table 160. Asia Gene Therapy Products Sales by Type (2021-2026) & (K Units) Table 161. Asia Gene Therapy Products Sales by Type (2027-2032) & (K Units) Table 162. Asia Gene Therapy Products Sales Price by Type (2021-2026) & (US$/Unit) Table 163. Asia Gene Therapy Products Sales Price by Type (2027-2032) & (US$/Unit) Table 164. Asia Gene Therapy Products Revenue by Application (2021-2026) & (US$ Million) Table 165. Asia Gene Therapy Products Revenue by Application (2027-2032) & (US$ Million) Table 166. Asia Gene Therapy Products Sales by Application (2021-2026) & (K Units) Table 167. Asia Gene Therapy Products Sales by Application (2027-2032) & (K Units) Table 168. Asia Gene Therapy Products Sales Price by Application (2021-2026) & (US$/Unit) Table 169. Asia Gene Therapy Products Sales Price by Application (2027-2032) & (US$/Unit) Table 170. Asia Gene Therapy Products Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 171. Asia Gene Therapy Products Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 172. Asia Gene Therapy Products Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 173. Asia Gene Therapy Products Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 174. Asia Gene Therapy Products Sales by Country (2021-2026) & (K Units) Table 175. Asia Gene Therapy Products Sales by Country (2027-2032) & (K Units) Table 176. Asia Gene Therapy Products Sales Price by Country (2021-2026) & (US$/Unit) Table 177. Asia Gene Therapy Products Sales Price by Country (2027-2032) & (US$/Unit) Table 178. Japan Gene Therapy Products Revenue (2021-2032) & (US$ Million) Table 179. South Korea Gene Therapy Products Revenue (2021-2032) & (US$ Million) Table 180. India Gene Therapy Products Revenue (2021-2032) & (US$ Million) Table 181. Australia Gene Therapy Products Revenue (2021-2032) & (US$ Million) Table 182. China Taiwan Gene Therapy Products Revenue (2021-2032) & (US$ Million) Table 183. Southeast Asia Gene Therapy Products Revenue (2021-2032) & (US$ Million) Table 184. SAMEA Gene Therapy Products Revenue by Type (2021-2026) & (US$ Million) Table 185. SAMEA Gene Therapy Products Revenue by Type (2027-2032) & (US$ Million) Table 186. SAMEA Gene Therapy Products Sales by Type (2021-2026) & (K Units) Table 187. SAMEA Gene Therapy Products Sales by Type (2027-2032) & (K Units) Table 188. SAMEA Gene Therapy Products Sales Price by Type (2021-2026) & (US$/Unit) Table 189. SAMEA Gene Therapy Products Sales Price by Type (2027-2032) & (US$/Unit) Table 190. SAMEA Gene Therapy Products Revenue by Application (2021-2026) & (US$ Million) Table 191. SAMEA Gene Therapy Products Revenue by Application (2027-2032) & (US$ Million) Table 192. SAMEA Gene Therapy Products Sales by Application (2021-2026) & (K Units) Table 193. SAMEA Gene Therapy Products Sales by Application (2027-2032) & (K Units) Table 194. SAMEA Gene Therapy Products Sales Price by Application (2021-2026) & (US$/Unit) Table 195. SAMEA Gene Therapy Products Sales Price by Application (2027-2032) & (US$/Unit) Table 196. SAMEA Gene Therapy Products Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 197. SAMEA Gene Therapy Products Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 198. SAMEA Gene Therapy Products Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 199. SAMEA Gene Therapy Products Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 200. SAMEA Gene Therapy Products Sales by Country (2021-2026) & (K Units) Table 201. SAMEA Gene Therapy Products Sales by Country (2027-2032) & (K Units) Table 202. SAMEA Gene Therapy Products Sales Price by Country (2021-2026) & (US$/Unit) Table 203. SAMEA Gene Therapy Products Sales Price by Country (2027-2032) & (US$/Unit) Table 204. Brazil Gene Therapy Products Revenue (2021-2032) & (US$ Million) Table 205. Argentina Gene Therapy Products Revenue (2021-2032) & (US$ Million) Table 206. Chile Gene Therapy Products Revenue (2021-2032) & (US$ Million) Table 207. Colombia Gene Therapy Products Revenue (2021-2032) & (US$ Million) Table 208. Peru Gene Therapy Products Revenue (2021-2032) & (US$ Million) Table 209. Saudi Arabia Gene Therapy Products Revenue (2021-2032) & (US$ Million) Table 210. Israel Gene Therapy Products Revenue (2021-2032) & (US$ Million) Table 211. UAE Gene Therapy Products Revenue (2021-2032) & (US$ Million) Table 212. Turkey Gene Therapy Products Revenue (2021-2032) & (US$ Million) Table 213. Iran Gene Therapy Products Revenue (2021-2032) & (US$ Million) Table 214. Egypt Gene Therapy Products Revenue (2021-2032) & (US$ Million) Table 215. Key Raw Materials Table 216. Raw Materials Key Suppliers Table 217. Gene Therapy Products Distributors List Table 218. Gene Therapy Products Customers List Table 219. Research Programs/Design for This Report Table 220. Authors List of This Report Table 221. Secondary Sources Table 222. Primary Sources List of Figures Figure 1. Gene Therapy Products Image Figure 2. Global Gene Therapy Products Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Gene Therapy Products Market Size Share 2021 VS 2025 VS 2032 Figure 4. Ex vivo Image Figure 5. In Vivo Image Figure 6. Global Gene Therapy Products Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Gene Therapy Products Market Size Share 2021 VS 2025 VS 2032 Figure 8. Cardiovascular disease Image Figure 9. Monogenic Image Figure 10. Infectious disease Image Figure 11. Cancer Image Figure 12. Other Image Figure 13. Global Gene Therapy Products Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global Gene Therapy Products Revenue (2021-2032) & (US$ Million) Figure 15. Global Gene Therapy Products Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 16. Global Gene Therapy Products Revenue Market Share by Region: 2025 Versus 2032 Figure 17. Global Gene Therapy Products Revenue Market Share by Region (2021-2032) Figure 18. Global Gene Therapy Products Sales (2021-2032) & (K Units) Figure 19. Global Gene Therapy Products Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 20. Global Gene Therapy Products Sales Market Share by Region (2021-2032) Figure 21. US & Canada & Mexico Gene Therapy Products Sales YoY (2021-2032) & (K Units) Figure 22. Europe Gene Therapy Products Sales YoY (2021-2032) & (K Units) Figure 23. China Gene Therapy Products Sales YoY (2021-2032) & (K Units) Figure 24. Asia (Excluding China) Gene Therapy Products Sales YoY (2021-2032) & (K Units) Figure 25. South America, Middle East and Africa Gene Therapy Products Sales YoY (2021-2032) & (K Units) Figure 26. Global Gene Therapy Products Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 27. Global Gene Therapy Products Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 28. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 29. Global Gene Therapy Products Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 30. Global Gene Therapy Products Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 31. Global Gene Therapy Products Revenue Market Share by Type (2021-2032) Figure 32. Global Gene Therapy Products Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 33. Global Gene Therapy Products Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 34. Global Gene Therapy Products Sales Market Share by Type (2021-2032) Figure 35. Global Gene Therapy Products Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 36. Global Gene Therapy Products Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 37. Global Gene Therapy Products Revenue Market Share by Application (2021-2032) Figure 38. Global Gene Therapy Products Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 39. Global Gene Therapy Products Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 40. Global Gene Therapy Products Sales Market Share by Application (2021-2032) Figure 41. North America Gene Therapy Products Revenue Share by Type (2021-2032) Figure 42. North America Gene Therapy Products Sales Share by Type (2021-2032) Figure 43. North America Gene Therapy Products Revenue Share by Application (2021-2032) Figure 44. North America Gene Therapy Products Sales Share by Application (2021-2032) Figure 45. North America Gene Therapy Products Revenue Share by Country (2021-2032) Figure 46. North America Gene Therapy Products Sales Share by Country (2021-2032) Figure 47. Europe Gene Therapy Products Revenue Share by Type (2021-2032) Figure 48. Europe Gene Therapy Products Sales Share by Type (2021-2032) Figure 49. Europe Gene Therapy Products Revenue Share by Application (2021-2032) Figure 50. Europe Gene Therapy Products Sales Share by Application (2021-2032) Figure 51. Europe Gene Therapy Products Revenue Share by Country (2021-2032) Figure 52. Europe Gene Therapy Products Sales Share by Country (2021-2032) Figure 53. China Gene Therapy Products Revenue Share by Type (2021-2032) Figure 54. China Gene Therapy Products Sales Share by Type (2021-2032) Figure 55. China Gene Therapy Products Revenue Share by Application (2021-2032) Figure 56. China Gene Therapy Products Sales Share by Application (2021-2032) Figure 57. Asia Gene Therapy Products Revenue Share by Type (2021-2032) Figure 58. Asia Gene Therapy Products Sales Share by Type (2021-2032) Figure 59. Asia Gene Therapy Products Revenue Share by Application (2021-2032) Figure 60. Asia Gene Therapy Products Sales Share by Application (2021-2032) Figure 61. Asia Gene Therapy Products Revenue Share by Country (2021-2032) Figure 62. Asia Gene Therapy Products Sales Share by Country (2021-2032) Figure 63. SAMEA Gene Therapy Products Revenue Share by Type (2021-2032) Figure 64. SAMEA Gene Therapy Products Sales Share by Type (2021-2032) Figure 65. SAMEA Gene Therapy Products Revenue Share by Application (2021-2032) Figure 66. SAMEA Gene Therapy Products Sales Share by Application (2021-2032) Figure 67. SAMEA Gene Therapy Products Revenue Share by Country (2021-2032) Figure 68. SAMEA Gene Therapy Products Sales Share by Country (2021-2032) Figure 69. Gene Therapy Products Value Chain Figure 70. Manufacturing Cost Structure Figure 71. Gene Therapy Products Production Mode & Process Figure 72. Direct Comparison with Distribution Share Figure 73. Distributors Profiles Figure 74. Years Considered Figure 75. Research Process Figure 76. Key Executives Interviewed

Scope & coverage.

Types
  • Ex vivo
  • In Vivo
Applications
  • Cardiovascular disease
  • Monogenic
  • Infectious disease
  • Cancer
  • Other
Companies covered
  • Advantagene
  • Avalanche Bio
  • Bluebird Bio
  • Celladon
  • Dimension Therapeutics
  • Sangamo
  • Spark Therapeutics
  • Vical Inc.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Gene Therapy Products Market by Type
  3. 1.2.1 Global Gene Therapy Products Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Ex vivo
  5. 1.2.3 In Vivo
  6. 1.3 Gene Therapy Products Market by Application
  7. 1.3.1 Global Gene Therapy Products Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Cardiovascular disease
  9. 1.3.3 Monogenic
  10. 1.3.4 Infectious disease
  11. 1.3.5 Cancer
  12. 1.3.6 Other
  13. 1.4 Assumptions and Limitations
  14. 1.5 Study Goals and Objectives
2 Gene Therapy Products Market Dynamics
  1. 2.1 Gene Therapy Products Industry Trends
  2. 2.2 Gene Therapy Products Industry Drivers
  3. 2.3 Gene Therapy Products Industry Opportunities and Challenges
  4. 2.4 Gene Therapy Products Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Gene Therapy Products Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Gene Therapy Products Revenue by Region
  3. 3.2.1 Global Gene Therapy Products Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Gene Therapy Products Revenue by Region (2021-2026)
  5. 3.2.3 Global Gene Therapy Products Revenue by Region (2027-2032)
  6. 3.2.4 Global Gene Therapy Products Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Gene Therapy Products Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Gene Therapy Products Sales by Region
  9. 3.4.1 Global Gene Therapy Products Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Gene Therapy Products Sales by Region (2021-2026)
  11. 3.4.3 Global Gene Therapy Products Sales by Region (2027-2032)
  12. 3.4.4 Global Gene Therapy Products Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Gene Therapy Products Revenue by Manufacturers
  2. 4.1.1 Global Gene Therapy Products Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Gene Therapy Products Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Gene Therapy Products Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Gene Therapy Products Sales by Manufacturers
  6. 4.2.1 Global Gene Therapy Products Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Gene Therapy Products Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Gene Therapy Products Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Gene Therapy Products Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Gene Therapy Products Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Gene Therapy Products Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Gene Therapy Products Manufacturers, Product Type & Application
  13. 4.7 Global Gene Therapy Products Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Gene Therapy Products Market CR5 and HHI
  16. 4.8.2 2025 Gene Therapy Products Tier 1, Tier 2, and Tier 3
5 Gene Therapy Products Market by Type
  1. 5.1 Global Gene Therapy Products Revenue by Type
  2. 5.1.1 Global Gene Therapy Products Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Gene Therapy Products Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Gene Therapy Products Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Gene Therapy Products Sales by Type
  6. 5.2.1 Global Gene Therapy Products Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Gene Therapy Products Sales by Type (2021-2032) & (K Units)
  8. 5.2.3 Global Gene Therapy Products Sales Market Share by Type (2021-2032)
  9. 5.3 Global Gene Therapy Products Price by Type
6 Gene Therapy Products Market by Application
  1. 6.1 Global Gene Therapy Products Revenue by Application
  2. 6.1.1 Global Gene Therapy Products Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Gene Therapy Products Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Gene Therapy Products Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Gene Therapy Products Sales by Application
  6. 6.2.1 Global Gene Therapy Products Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Gene Therapy Products Sales by Application (2021-2032) & (K Units)
  8. 6.2.3 Global Gene Therapy Products Sales Market Share by Application (2021-2032)
  9. 6.3 Global Gene Therapy Products Price by Application
7 Company Profiles
  1. 7.1 Advantagene
  2. 7.1.1 Advantagene Company Information
  3. 7.1.2 Advantagene Business Overview
  4. 7.1.3 Advantagene Gene Therapy Products Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Advantagene Gene Therapy Products Product Portfolio
  6. 7.1.5 Advantagene Recent Developments
  7. 7.2 Avalanche Bio
  8. 7.2.1 Avalanche Bio Company Information
  9. 7.2.2 Avalanche Bio Business Overview
  10. 7.2.3 Avalanche Bio Gene Therapy Products Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Avalanche Bio Gene Therapy Products Product Portfolio
  12. 7.2.5 Avalanche Bio Recent Developments
  13. 7.3 Bluebird Bio
  14. 7.3.1 Bluebird Bio Company Information
  15. 7.3.2 Bluebird Bio Business Overview
  16. 7.3.3 Bluebird Bio Gene Therapy Products Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Bluebird Bio Gene Therapy Products Product Portfolio
  18. 7.3.5 Bluebird Bio Recent Developments
  19. 7.4 Celladon
  20. 7.4.1 Celladon Company Information
  21. 7.4.2 Celladon Business Overview
  22. 7.4.3 Celladon Gene Therapy Products Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Celladon Gene Therapy Products Product Portfolio
  24. 7.4.5 Celladon Recent Developments
  25. 7.5 Dimension Therapeutics
  26. 7.5.1 Dimension Therapeutics Company Information
  27. 7.5.2 Dimension Therapeutics Business Overview
  28. 7.5.3 Dimension Therapeutics Gene Therapy Products Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Dimension Therapeutics Gene Therapy Products Product Portfolio
  30. 7.5.5 Dimension Therapeutics Recent Developments
  31. 7.6 Sangamo
  32. 7.6.1 Sangamo Company Information
  33. 7.6.2 Sangamo Business Overview
  34. 7.6.3 Sangamo Gene Therapy Products Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Sangamo Gene Therapy Products Product Portfolio
  36. 7.6.5 Sangamo Recent Developments
  37. 7.7 Spark Therapeutics
  38. 7.7.1 Spark Therapeutics Company Information
  39. 7.7.2 Spark Therapeutics Business Overview
  40. 7.7.3 Spark Therapeutics Gene Therapy Products Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Spark Therapeutics Gene Therapy Products Product Portfolio
  42. 7.7.5 Spark Therapeutics Recent Developments
  43. 7.8 Vical Inc.
  44. 7.8.1 Vical Inc. Company Information
  45. 7.8.2 Vical Inc. Business Overview
  46. 7.8.3 Vical Inc. Gene Therapy Products Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Vical Inc. Gene Therapy Products Product Portfolio
  48. 7.8.5 Vical Inc. Recent Developments
8 North America
  1. 8.1 North America Gene Therapy Products Market Size by Type
  2. 8.1.1 North America Gene Therapy Products Revenue by Type (2021-2032)
  3. 8.1.2 North America Gene Therapy Products Sales by Type (2021-2032)
  4. 8.1.3 North America Gene Therapy Products Price by Type (2021-2032)
  5. 8.2 North America Gene Therapy Products Market Size by Application
  6. 8.2.1 North America Gene Therapy Products Revenue by Application (2021-2032)
  7. 8.2.2 North America Gene Therapy Products Sales by Application (2021-2032)
  8. 8.2.3 North America Gene Therapy Products Price by Application (2021-2032)
  9. 8.3 North America Gene Therapy Products Market Size by Country
  10. 8.3.1 North America Gene Therapy Products Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Gene Therapy Products Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Gene Therapy Products Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
9 Europe
  1. 9.1 Europe Gene Therapy Products Market Size by Type
  2. 9.1.1 Europe Gene Therapy Products Revenue by Type (2021-2032)
  3. 9.1.2 Europe Gene Therapy Products Sales by Type (2021-2032)
  4. 9.1.3 Europe Gene Therapy Products Price by Type (2021-2032)
  5. 9.2 Europe Gene Therapy Products Market Size by Application
  6. 9.2.1 Europe Gene Therapy Products Revenue by Application (2021-2032)
  7. 9.2.2 Europe Gene Therapy Products Sales by Application (2021-2032)
  8. 9.2.3 Europe Gene Therapy Products Price by Application (2021-2032)
  9. 9.3 Europe Gene Therapy Products Market Size by Country
  10. 9.3.1 Europe Gene Therapy Products Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Gene Therapy Products Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Gene Therapy Products Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Netherlands
10 China
  1. 10.1 China Gene Therapy Products Market Size by Type
  2. 10.1.1 China Gene Therapy Products Revenue by Type (2021-2032)
  3. 10.1.2 China Gene Therapy Products Sales by Type (2021-2032)
  4. 10.1.3 China Gene Therapy Products Price by Type (2021-2032)
  5. 10.2 China Gene Therapy Products Market Size by Application
  6. 10.2.1 China Gene Therapy Products Revenue by Application (2021-2032)
  7. 10.2.2 China Gene Therapy Products Sales by Application (2021-2032)
  8. 10.2.3 China Gene Therapy Products Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Gene Therapy Products Market Size by Type
  2. 11.1.1 Asia Gene Therapy Products Revenue by Type (2021-2032)
  3. 11.1.2 Asia Gene Therapy Products Sales by Type (2021-2032)
  4. 11.1.3 Asia Gene Therapy Products Price by Type (2021-2032)
  5. 11.2 Asia Gene Therapy Products Market Size by Application
  6. 11.2.1 Asia Gene Therapy Products Revenue by Application (2021-2032)
  7. 11.2.2 Asia Gene Therapy Products Sales by Application (2021-2032)
  8. 11.2.3 Asia Gene Therapy Products Price by Application (2021-2032)
  9. 11.3 Asia Gene Therapy Products Market Size by Country
  10. 11.3.1 Asia Gene Therapy Products Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Gene Therapy Products Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Gene Therapy Products Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Gene Therapy Products Market Size by Type
  2. 12.1.1 SAMEA Gene Therapy Products Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Gene Therapy Products Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Gene Therapy Products Price by Type (2021-2032)
  5. 12.2 SAMEA Gene Therapy Products Market Size by Application
  6. 12.2.1 SAMEA Gene Therapy Products Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Gene Therapy Products Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Gene Therapy Products Price by Application (2021-2032)
  9. 12.3 SAMEA Gene Therapy Products Market Size by Country
  10. 12.3.1 SAMEA Gene Therapy Products Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Gene Therapy Products Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Gene Therapy Products Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Gene Therapy Products Value Chain Analysis
  2. 13.1.1 Gene Therapy Products Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Gene Therapy Products Production Mode & Process
  6. 13.2 Gene Therapy Products Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Gene Therapy Products Distributors
  9. 13.2.3 Gene Therapy Products Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst